Peter McCormick has a degree in Chemistry from Washington University in St. Louis, USA and a PhD in Biochemistry and Biophysics from Texas A&M University, USA. His lab studies the molecular underpinnings of diseases. Their focus is on the role of the super family of G-protein coupled receptors (GPCR) in these mechanisms. His work in GPCRs has been published in Science, PNAS, PLoS Biology, Molecular Psychiatry, JBC, JNCI, BMC Biology, Molecular Pharmacology, eLife, and the Journal of Neuroscience.  He has worked with GSK, Sosei-Heptares, Neurolixis and sits on the scientific advisory board of CrystalBio (Shenzhen) and Cumulus Oncology (UK).

He is currently the associate pro-vice chancellor for International Partnerships and Postgraduate Affairs and Chair in Pharmacology at the University of Liverpool.